Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$27,000.00

Examining a key regulatory mechanism for glutamatergic signaling in the spinal dorsal horn

EF 2011-12

Résumé
The majority of excitatory transmission in the central nervous system (CNS) is carried out by the excitatory amino acid glutamate. Regulating the levels of extracellular glutamate at the synapse is an integral process in neurotransmission. Its rapid clearance from the extracellular space is carried out by a family of Na+-dependent, high affinity transporters for glutamate, the glutamate transporters. These transporters prevent glutamate-induced excitoxicity in the CNS, limit ""spillover"" of glutamate into nearby synapses and are critical for shaping activity at synaptic and extrasynaptic glutamate receptor complexes. One region in the CNS where the glutamate transporters appear to play a key role in regulating neuronal excitability is in the spinal dorsal horn, the site where noxious sensory input is initially processed. However, determining the specific contribution of the glutamate transporters in controlling the sensitivity and excitability of dorsal horn cells has been hampered by a lack of specific pharmacological tools. The MAIN OBJECTIVE of my research program is to understand how the glutamate transporters regulate glutamatergic signaling and thus, the excitability of sensory pathways in the dorsal horn of the spinal cord. The first objective of this research is to use viral vectors to manipulate the expression of a specific glutamate transporter subtype, EAAT-2, in the spinal dorsal horn and assess how this affects glutamate receptor activation and sensory function. A second objective is to understand the specific mechanisms that control glutamate transporter expression in the CNS. My research program will provide much needed insight into how glutamate transporters modulate glutamate receptor activity and sensory function. In addition, it will help to elucidate the key regulatory pathways and factors that control glutamate transporter expression and activity.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
386547-2010
Name nom
Kerr, Bradley
Department département
Anesthesiology and Pain Medicine
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
27000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
2
Nb partie
5
Application title
Examining a key regulatory mechanism for glutamatergic signaling in the spinal dorsal horn
Keyword
NSERC
Application summary
The majority of excitatory transmission in the central nervous system (CNS) is carried out by the excitatory amino acid glutamate. Regulating the levels of extracellular glutamate at the synapse is an integral process in neurotransmission. Its rapid clearance from the extracellular space is carried out by a family of Na+-dependent, high affinity transporters for glutamate, the glutamate transporters. These transporters prevent glutamate-induced excitoxicity in the CNS, limit ""spillover"" of glutamate into nearby synapses and are critical for shaping activity at synaptic and extrasynaptic glutamate receptor complexes. One region in the CNS where the glutamate transporters appear to play a key role in regulating neuronal excitability is in the spinal dorsal horn, the site where noxious sensory input is initially processed. However, determining the specific contribution of the glutamate transporters in controlling the sensitivity and excitability of dorsal horn cells has been hampered by a lack of specific pharmacological tools. The MAIN OBJECTIVE of my research program is to understand how the glutamate transporters regulate glutamatergic signaling and thus, the excitability of sensory pathways in the dorsal horn of the spinal cord. The first objective of this research is to use viral vectors to manipulate the expression of a specific glutamate transporter subtype, EAAT-2, in the spinal dorsal horn and assess how this affects glutamate receptor activation and sensory function. A second objective is to understand the specific mechanisms that control glutamate transporter expression in the CNS. My research program will provide much needed insight into how glutamate transporters modulate glutamate receptor activity and sensory function. In addition, it will help to elucidate the key regulatory pathways and factors that control glutamate transporter expression and activity.